Works by Shah, Bijal D.

Results: 12

Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.

Published in:

Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01379-0

By:

Shah, Bijal D.;
Ghobadi, Armin;
Oluwole, Olalekan O.;
Logan, Aaron C.;
Boissel, Nicolas;
Cassaday, Ryan D.;
Leguay, Thibaut;
Bishop, Michael R.;
Topp, Max S.;
Tzachanis, Dimitrios;
O'Dwyer, Kristen M.;
Arellano, Martha L.;
Lin, Yi;
Baer, Maria R.;
Schiller, Gary J.;
Park, Jae H.;
Subklewe, Marion;
Abedi, Mehrdad;
Minnema, Monique C.;
Wierda, William G.

Publication type:

Article

Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States.

Published in:

2022

By:

Shah, Bijal D.;
Smith, Nathaniel J.;
Feng, Chaoling;
Jeyakumar, Sushanth;
Castaigne, Jean-Gabriel;
Faghmous, Imi;
Masouleh, Behzad Kharabi;
Malone, Daniel C.;
Bishop, Michael R.

Publication type:

journal article

Outcomes of patients aged ≥26 years with relapsed or refractory B-cell acute lymphoblastic leukemia in ZUMA-3 and historical trials.

Published in:

Leukemia & Lymphoma, 2024, v. 65, n. 10, p. 1438, doi. 10.1080/10428194.2024.2353877

By:

Minnema, Monique C.;
Yin, Xiang;
Davi, Ruthanna;
Keeping, Sam;
Park, Julie E.;
Itani, Taha;
Hadjivassileva, Tsveta;
Castaigne, Jean-Gabriel;
Damico Khalid, Rita;
Zhou, Lang;
Wu, James J.;
Shah, Bijal D.

Publication type:

Article

Frontline treatment approaches in TP53-aberrant mantle cell lymphoma.

Published in:

Leukemia & Lymphoma, 2023, v. 64, n. 1, p. 230, doi. 10.1080/10428194.2022.2131407

By:

Shah, Nikesh N.;
Castillo-Tokumori, Franco;
Whiting, Junmin;
Boulware, David;
Sandoval-Sus, Jose;
Knepper, Todd C.;
Hussaini, Mohammad;
Tao, Jianguo;
Chavez, Julio C.;
Isenalumhe, Leidy;
Gaballa, Sameh;
Saeed, Hayder;
Bello, Celeste;
Sokol, Lubomir;
Pinilla-Ibarz, Javier;
Shah, Bijal D.

Publication type:

Article

B-Lymphoblastic Leukemia/Lymphoma Associated with t(8;13)(p11;q12)/ZMYM2 (ZNF198)-FGFR1: Rare Case and Review of the Literature.

Published in:

Acta Haematologica, 2013, v. 130, n. 3, p. 127, doi. 10.1159/000347030

By:

Trimaldi, Janese;
Carballido, Estrella M.;
Bowers, Jeremy W.;
anguiano, arturo L.;
Zhang, Zhong J.;
Shah, Bijal D.;
Bruno, Salvador;
List, alan F.;
Moscinski, Lynn C.;
Grady, Terrence;
agosti, Steven J.;
Kang, Loveleen;
Zhang, Ling

Publication type:

Article

Sequencing antigen‐targeting antibodies and cellular therapies in adults with relapsed/refractory B‐cell acute lymphoblastic leukemia.

Published in:

American Journal of Hematology, 2023, v. 98, n. 4, p. 666, doi. 10.1002/ajh.26853

By:

Aldoss, Ibrahim;
Shah, Bijal D.;
Park, Jae H.;
Muffly, Lori;
Logan, Aaron C.;
Brown, Patrick;
Stock, Wendy;
Jabbour, Elias J.

Publication type:

Article

Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomab.

Published in:

Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01179-4

By:

Jabbour, Elias J.;
Kantarjian, Hagop M.;
Goekbuget, Nicola;
Shah, Bijal D.;
Chiaretti, Sabina;
Park, Jae H.;
Rijneveld, Anita W.;
Gore, Lia;
Fleming, Shaun;
Logan, Aaron C.;
Ribera, Josep M.;
Menne, Tobias F.;
Mezzi, Khalid;
Zaman, Faraz;
Velasco, Kelly;
Boissel, Nicolas

Publication type:

Article

KTE-C19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL): Outcomes in Patients Who Were Treated with Prior Blinatumomab in ZUMA-3.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S184, doi. 10.1016/j.clml.2018.07.015

By:

Shah, Bijal D.;
Oluwole, Olalekan O.;
Baer, Maria R.;
Bishop, Michael R.;
Holmes, Houston;
Schiller, Gary J.;
Donnellan, William;
O'Dwyer, Kristen M.;
Mardiros, Armen;
Rossi, John M.;
Shen, Tong;
Xue, Allen;
Jain, Rajul K.;
Vezan, Remus;
Wierda, William G.

Publication type:

Article

Assessment of Clonotypic Rearrangements and Minimal Residual Disease in Lymphoid Malignancies: A Large Cancer Center Experience Using clonoSEQ.

Published in:

Archives of Pathology & Laboratory Medicine, 2022, v. 146, n. 4, p. 485, doi. 10.5858/arpa.2020-0457-OA

By:

Hussaini, Mohammad O.;
Srivastava, Jaya;
Lik Wee Lee;
Taiga Nishihori;
Shah, Bijal D.;
Alsina, Melissa;
Pinilla-Ibarz, Javier;
Shain, Kenneth H.

Publication type:

Article

Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel.

Published in:

Cancer Medicine, 2021, v. 10, n. 6, p. 1936, doi. 10.1002/cam4.3664

By:

Hoogland, Aasha I.;
Jayani, Reena V.;
Collier, Aaron;
Irizarry‐Arroyo, Nathaly;
Rodriguez, Yvelise;
Jain, Michael D.;
Booth‐Jones, Margaret;
Hyland, Kelly A.;
James, Brian W.;
Barata, Anna;
Bachmeier, Christina A.;
Chavez, Julio C.;
Khimani, Farhad;
Krivenko, Gabriel S.;
Lazaryan, Aleksandr;
Liu, Hien D.;
Nishihori, Taiga;
Pinilla‐Ibarz, Javier;
Shah, Bijal D.;
Abidi, Muneer

Publication type:

Article

Response to Boctor and Smith.

Published in:

American Journal of Hematology, 2008, v. 83, n. 3, p. 256, doi. 10.1002/ajh.21079

By:

Whitlatch, Nicole L.;
Martin, Michael G.;
Shah, Bijal D.;
Arepally, Gowthami M.

Publication type:

Article

PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas.

Published in:

2018

By:

Yuan Ren;
Chengfeng Bi;
Xiaohong Zhao;
Tint Lwin;
Cheng Wang;
Ji Yuan;
Silva, Ariosto S.;
Shah, Bijal D.;
Fang, Bin;
Tao Li;
Koomen, John M.;
Huijuan Jiang;
Chavez, Julio C.;
Pham, Lan V.;
Sudalagunta, Praneeth R.;
Lixin Wan;
Xuefeng Wang;
Dalton, William S.;
Moscinski, Lynn C.;
Shain, Kenneth H.

Publication type:

journal article